Get started

Earningsreport

Arista Networks Dips 4% Premarket Despite Strong Q4 FinancialsArista Networks (NASDAQ: NYSE:ANET ) saw a 4% dip in premarket trading despite delivering better-than-expected revenue and earnings in its latest quarterly report. The stock's recent movement raises questions about market sentiment and potential buying opportunities. Strong Revenue and Earnings Growth Arista Networks, a leader in cloud networking, reported a fourth-quarter revenue of $1.93 billion, reflecting a 7% year-over-year increase. This beat analyst estimates and demonstrated the company’s ability to sustain growth even amid economic uncertainty. Net earnings surged to $830.1 million (65 cents per share), compared to $664.3 million (52 cents per share) in the prior year. These strong financials reflect Arista’s continued dominance in the cloud networking industry, particularly as it pushes further into AI-driven initiatives. Additionally, Arista Networks provided an optimistic forecast for the first quarter of 2024, expecting revenue between $1.93 billion and $1.97 billion, surpassing analysts' expectations. This suggests that despite short-term price volatility, the company’s long-term growth remains intact. Market Sentiment and Analyst Ratings Despite the positive earnings report, NYSE:ANET faced early selling pressure. However, analysts remain bullish on the stock, with an average "Buy" rating from 15 analysts. The 12-month price forecast stands at $108.38, representing a slight downside of -3.12% from the latest price, indicating that the market might already be factoring in Arista’s growth potential. Technical Analysis From a technical perspective, NYSE:ANET ’s premarket drop of 4.11% has placed its Relative Strength Index (RSI) at 47, signaling that the stock is approaching oversold territory but not yet at extreme levels. Currently, the stock is trading above key moving averages (MA), suggesting that the broader uptrend remains intact. However, the dip brings NYSE:ANET close to its one-month low, a temporary support level that traders should watch closely. If selling pressure continues, a break below this level could lead to further downside. That said, this retracement could also be a strategic move to sweep liquidity and attract demand for a potential rebound. Investors should watch for price stabilization and confirmation of renewed buying interest before making any decisive moves. Conclusion Despite the early sell-off, Arista Networks’ strong fundamentals, growing revenue, and positive long-term outlook position it as a solid investment choice. The recent dip may be an opportunity for traders to capitalize on a short-term pullback before the stock resumes its upward trajectory. As always, monitoring key technical levels and broader market trends will be crucial in assessing NYSE:ANET ’s next move.
NYSE:ANETLong
by DEXWireNews
Allegion (NYSE: $ALLE) Prepares for Q4 Earnings: Will It Break?Allegion plc (NYSE: ALLE), a key player in the security hardware industry, is set to announce its Q4 earnings today before the market opens. The stock has gained 1.7% in premarket trading, reflecting cautious optimism from investors. With expectations of a 4.5% year-over-year revenue increase to $937.9 million and adjusted earnings of $1.75 per share, the question remains: will Allegion meet expectations or face another revenue miss? Steady Growth Amid Mixed Performance Last quarter, Allegion met revenue expectations, posting $967.1 million in sales, a 5.4% YoY increase. However, the company slightly missed organic revenue estimates despite surpassing full-year EPS projections. Over the last two years, Allegion has fallen short of Wall Street’s revenue expectations three times, adding an element of uncertainty heading into today’s report. Comparing Allegion to its peers in the electrical systems sector, LSI reported a significant 35.5% revenue surge, beating estimates by 14.3%, while Vertiv grew 25.8%, exceeding expectations by 8.8%. Despite these positive trends, the sector has underperformed recently, with an average stock decline of 4.6% over the past month, and Allegion itself dropping 1.2% in the same period. The broader market landscape in 2024 has been favorable. The Federal Reserve successfully controlled inflation without triggering a recession, leading to a "soft landing." Additionally, the election of Donald Trump in November 2024 has fueled market momentum. However, electrical systems stocks have lagged, making Allegion’s upcoming earnings report crucial for its near-term trajectory. Technical Analysis Currently, ALLE is up 1.95% in Tuesday’s premarket trading. The stock’s RSI stands at 54.83, indicating neutral momentum, while trading volume continues to rise ahead of earnings. If Allegion delivers strong Q4 results, it could break above its one-month high, which currently acts as a resistance zone. On the downside, a negative earnings report could trigger a retracement toward the 38.2% Fibonacci retracement level. The direction of ALLE’s movement will largely depend on whether it can surpass investor expectations or confirm concerns about its revenue consistency. What’s Next for ALLE? With analysts maintaining stable estimates and market conditions favoring growth stocks, Allegion’s Q4 results will play a key role in determining its short-term price action. A bullish breakout could propel it towards the analyst target of $143.75, while a miss may lead to further downside. Investors should watch today’s earnings closely to gauge the stock’s next major move.
NYSE:ALLELong
by DEXWireNews
Gilead Sciences (GILD) Soars 4.93% on Strong Q4 Earnings ReportsGilead Sciences (NASDAQ: NASDAQ:GILD ) is making waves in the biotech sector after delivering a stellar fourth-quarter earnings report that not only crushed Wall Street expectations but also set the stage for a promising 2025. The stock surged 4.50% in premarket trading on Wednesday, signaling strong investor confidence in the company’s growth trajectory. Quarter and Optimistic Guidance Gilead’s Q4 earnings report was nothing short of impressive. The company posted adjusted earnings of $1.90 per share, a 10.5% year-over-year increase, and handily beat analysts’ estimates of $1.74. Revenue climbed 6% to $7.57 billion, surpassing the consensus forecast of $7.15 billion. HIV Franchise Shines Bright Gilead’s HIV portfolio remains its crown jewel. Biktarvy, the company’s flagship HIV treatment, generated $3.8 billion in sales, up 21% year-over-year and well ahead of the $3.47 billion forecast. Descovy, another HIV drug, also outperformed expectations, with sales rising 21% to $616 million. Combined, Gilead’s HIV product sales reached $5.45 billion, up 16% from the previous year. Looking ahead, Gilead is poised to expand its HIV franchise further with the anticipated mid-2025 launch of lenacapavir, a twice-yearly injectable for HIV prevention. The U.S. Food and Drug Administration (FDA) is expected to make a decision on the drug by mid-2024, and its approval could be a significant growth catalyst. Oncology and Liver Disease: Steady Growth Gilead’s oncology and liver disease segments also contributed to the strong quarter. Sales of its cell therapies for cancer treatment rose 5% to $488 million, beating expectations of $476 million. Trodelvy, a cancer drug, saw sales jump 19% to $355 million, surpassing the $324 million forecast. Liver disease treatments brought in $719 million, up 4% year-over-year. Veklury: The Only Blemish The only downside in Gilead’s report was Veklury, its COVID-19 treatment. Sales plummeted 53% to $337 million due to lower hospitalizations, particularly in the U.S. Upbeat 2025 Guidance Gilead’s bullish outlook for 2025 further fueled investor optimism. The company expects adjusted earnings of $7.70 to $8.10 per share on product sales of $28.2 billion to $28.6 billion. The midpoint of this guidance exceeds analysts’ estimates of $7.61 per share and $28.35 billion in revenue. Technical Analysis From a technical perspective, Gilead’s stock is showing strong bullish signals. As of Wednesday’s premarket trading, GILD is up 4.93%, poised to form a gap-up pattern upon market open. Key Levels to Watch - Resistance: A breakout above the 1-month high of $100 could serve as a critical catalyst for a sustained bullish run. This level represents a psychological barrier, and a decisive move above it could attract more buyers. - Support: In the event of a pullback, immediate support lies at the 65% Fibonacci retracement level, which aligns with the $92 mark. This level could act as a springboard for renewed upward momentum. RSI Indicates Room for Growth The Relative Strength Index (RSI) stands at 55, indicating that the stock is neither overbought nor oversold. This suggests there is ample room for further upside, especially if the broader market sentiment remains favorable. Conclusion Gilead Sciences (GILD) is firing on all cylinders, with a strong Q4 earnings beat, robust guidance for 2025, and a promising pipeline. The company’s leadership in the HIV market, coupled with its growing presence in oncology and liver disease, positions it well for long-term growth. From a technical standpoint, the stock is primed for a breakout, with key resistance and support levels offering clear markers for traders and investors.
NASDAQ:GILDLong
by DEXWireNews
Breaking: Doximity Stock Jumps 37% On Upbeat Annual OutlookDoximity Inc. (NASDAQ: DOCS), the leading digital platform for U.S. medical professionals, has made headlines with its stock skyrocketing 37% following a stellar earnings report and an upbeat annual outlook. The company’s third-quarter fiscal 2025 results not only surpassed analyst expectations but also showcased robust growth in key areas, including AI tools and user engagement. Strong Earnings and Upbeat Guidance Doximity’s latest earnings report has solidified its position as a growth powerhouse in the healthcare technology sector. Here are the key highlights: 1. Record Revenue and Earnings Growth - Revenue: $168.6 million, up 25% year-over-year, beating consensus estimates of $152.82 million. - Earnings Per Share (EPS): Adjusted EPS of $0.45, a significant jump from $0.29 a year ago and well above the $0.34 consensus. - Net Income: $75.2 million, up 57% year-over-year, reflecting strong profitability. 2. AI Tools and User Engagement Driving Growth Doximity’s AI-powered tools saw a 60% quarter-over-quarter increase in usage, while its newsfeed surpassed one million unique providers. This demonstrates the platform’s ability to innovate and retain user engagement, which is critical for long-term growth. 3. Raised Guidance for Fiscal 2025 The company raised its revenue guidance to $564.6 million—$565.6 million, up from the previous range of $535 million—$540 million. Adjusted EBITDA guidance was also increased to $306.6 million—$307.6 million, signaling confidence in continued profitability and operational efficiency. 4. Analyst Optimism Analysts have responded positively to Doximity’s performance: - Needham: Raised price target from $65 to $82, maintaining a Buy rating. - Wells Fargo: Increased price target from $43 to $55, maintaining an Equal-Weight rating. - Raymond James: Raised price target from $65 to $83, reiterating an Outperform rating. These upward revisions reflect growing confidence in Doximity’s ability to sustain its momentum. Technical Analysis: From a technical perspective, NYSE:DOCS is exhibiting a classic gap-up pattern, with shares up 35.68% at the time of writing. Here’s what the charts are telling us: 1. Gap-Up Pattern The gap-up indicates a surge in buying interest following the earnings announcement. While this is a bullish signal, gaps are often filled in the long run, meaning the stock could retrace some of its gains before continuing its upward trajectory. 2. The Relative Strength Index (RSI) is currently at 86, well above the overbought threshold of 70. This suggests that the stock may be due for a short-term pullback or consolidation as traders take profits. 3. Despite overbought conditions, the stock’s momentum remains strong. Key support levels to watch include the pre-gap price zone around $61. A pullback to this area could present a buying opportunity for investors looking to enter at a lower price. Why Doximity Stands Out Doximity’s success is rooted in its ability to address critical needs in the healthcare industry. Its digital platform streamlines communication and workflow for medical professionals, while its AI tools enhance efficiency and decision-making. With over 610,000 unique providers using its clinical workflow tools, Doximity has established itself as an indispensable resource for healthcare professionals. A Strong Buy with Caution Doximity’s impressive earnings report and raised guidance have rightfully propelled its stock to new heights. From a fundamental perspective, the company’s growth trajectory, driven by AI innovation and user engagement, is compelling. Technically, while the stock is overbought in the short term, the long-term outlook remains bullish.
NYSE:DOCSLong
by DEXWireNews
Barrick Gold Corporation ($ABX): Golden Opportunity or Risky Barrick Gold Corporation (ABX): Golden Opportunity or Risky Prospect? 🏆💰 1/10 Barrick Gold TSX:ABX has seen a solid financial performance recently. EPS for the last quarter hit C$0.42, with next quarter estimates at C$0.63. They beat estimates 75% of the time in the past year. 📈 2/10 Analysts are bullish! The average price target is C$33.57, implying a potential upside of 50.13% from the current C$22.36 price. Strong Buy ratings dominate: 10 Buy, 2 Hold. 🔍 What do analysts know that the market doesn’t? 3/10 However, ABX is facing operational challenges. A suspension in Mali due to government intervention highlights geopolitical risks in mining. 🛑 Regulatory challenges are part of the gold mining game. 4/10 Stock price check: ABX currently trades at C$23.15. That’s 20.94% below its 52-week high of C$29.28 but 21.59% above its low. What does this tell us? Room for recovery, but risks loom. 📊 5/10 Valuation time! Compared to sector peers, Barrick offers an attractive price level, especially given the 50% upside target. Analysts love undervalued plays like this, but what about the risks? 🤔 6/10 Strengths: Barrick operates across multiple countries, ensuring diversified production. That’s crucial in a volatile gold market. 🌍 Diversification is a key defensive strategy here. 7/10 Challenges: High operational costs are always a concern. Pair that with political instability, like the Mali suspension, and ABX faces a steep uphill climb. 🏔️ How much risk are you willing to take on? 8/10 Opportunities: Expansion is always on the table. With gold prices looking stable, Barrick could capitalize on new projects or mines. But timing matters in this market. ⛏️ 9/10 Threats: Regulatory and political risks never sleep. Changes in mining laws or political unrest can hit Barrick hard—Mali’s situation is a prime example. Always know your risks. ⚠️ 10/10 What’s your take on Barrick Gold TSX:ABX ? Will it strike gold again? Vote here! 🗳️ Buy for the long term 📈 Hold and watch growth 🔄 Too risky, avoid 🚫
TSX:ABXLong
by DCAChampion
2
Apple Surges 3% in Premarket Amid AI Optimism & Strong ForecastApple Inc. (NASDAQ: NASDAQ:AAPL ) has seen a notable 3.46% surge in premarket trading, defying concerns over declining China sales. The upward momentum follows an optimistic sales forecast, hinting at a resurgence in iPhone demand fueled by Apple's strategic adoption of artificial intelligence (AI) features. Earnings Outlook Apple’s latest earnings report revealed a nuanced performance, with robust overall revenue counterbalanced by a slight dip in iPhone sales. Despite a shortfall in China, where revenue declined 11% to $18.5 billion—falling short of the projected $21.57 billion—Apple’s services unit exhibited strong growth, climbing 14% year-over-year to $26.34 billion. This exceeded Wall Street expectations of $26.09 billion, reinforcing Apple’s ability to diversify revenue streams beyond hardware sales. CEO Tim Cook emphasized that Apple Intelligence, the company’s AI-powered suite of features, is playing a crucial role in boosting iPhone sales where available. However, Apple’s cautious approach to AI investments, unlike its peers such as Microsoft (MSFT) and Meta (META), has insulated its stock from recent market turbulence. The restrained AI strategy aligns with Apple's focus on integrating AI within its hardware ecosystem, enhancing device functionality without excessive capital expenditure on data centers. The company posted earnings of $2.42 per share on revenue of $124.3 billion, surpassing analyst expectations of $2.36 EPS on $124.12 billion revenue. While iPhone sales, accounting for nearly half of Apple's revenue, declined to $69.14 billion from $69.70 billion year-over-year, the broader growth trajectory suggests a potential iPhone rebound in FY26. Technical Outlook From a technical standpoint, NASDAQ:AAPL is demonstrating strong bullish patterns. The stock is currently up 3.41%, benefiting from the renewed confidence in its growth trajectory. Prior to this recent rally, Apple shares had experienced a 15% decline since late December 2024. However, the current price action suggests a recovery, with NASDAQ:AAPL reclaiming 10% of its lost value, forming a falling wedge pattern—a historically bullish signal. The premarket surge sets up the possibility of a gap-up pattern at market open, a strong bullish indicator that could further accelerate buying pressure. In the event of a pullback, immediate support lies at the 61.8% Fibonacci retracement level, a key level that often dictates price reversals in technical analysis. The China Factor and AI’s Role in Future Growth While Apple’s sales slump in China remains a wildcard, analysts expect a recovery once Apple Intelligence is introduced in the region. The lack of AI features has been cited as a major reason for weaker-than-expected sales in the Chinese market. TD Cowen analysts predict that demand could rebound once Apple secures a local partner to facilitate AI integration, boosting sales in a highly competitive market. Moreover, Apple's performance relative to its tech peers remains strong. In 2024, Apple stock surged 30.07%, outperforming Microsoft’s 12.09% increase but trailing Meta’s impressive 65.42% rise. Apple’s 12-month forward price-to-earnings (P/E) ratio stands at 31.12, compared to Microsoft’s 29.2 and Meta’s 26, indicating sustained investor confidence in Apple’s long-term growth potential. AAPL Positioned for Further Gains Apple’s ability to weather market challenges, coupled with its strategic AI rollout, positions it favorably for continued growth. The bullish technical setup, strong fundamentals, and AI-driven sales optimism indicate that AAPL could maintain its upward trajectory. Investors should monitor key support and resistance levels, as well as further developments regarding Apple Intelligence’s expansion into new markets. With analysts raising price targets and market sentiment improving, Apple’s stock could be on track for a sustained rally in 2024 and beyond.
NASDAQ:AAPLLong
by DEXWireNews
Huge Earnings and Economic Surprises Ahead!🚨 Weekly Preview: Big Earnings and Economic News 🚨 Get ready for an action-packed week as we dive into major corporate earnings reports and crucial economic updates! 📊💼 🔍 Earnings Highlights: Tech giants like Apple, Microsoft, and Tesla are set to release their quarterly results. Also, goliaths such as Visa, Mastercard, ASML and more! 📈 Economic Indicators to Watch: Inflation rates 📉 GDP Growth 📊 Federal Reserve policy decisions 💵 Stay tuned for in-depth analysis and insights on how these events could shape market trends and investor sentiment. Don't miss out on the key information that could impact your financial decisions! 📅📢
NYSE:NOWLong
by RonnieV29
3
[01/20] GEX Outlook: Decision, Key Levels and Looming VolatilityLooking at the GEX levels through Friday, we can see that since mid-December, the market has been moving in a slightly downward channel. Above 6000–6025: A call gamma squeeze is expected. Between 5925 and 6000: A sideways “chop zone.” Below 5925: The high-volatility zone begins, with 5800–5850 acting as our major support/resistance level characterized by heavy put dominance. Below that level lies a “total denial zone.” We’ve seen this scenario before—think back to the red candle on December 18, when the price broke below that threshold. This “red zone” is currently around 5800, so below 5925 we can anticipate large-amplitude moves. At this point, the market still does not seem worried about significant volatility. Until Friday, all NETGEX values for every expiration are positive , so market participants are pricing in more of a sideways movement. We haven’t yet seen a big pickup in volatility. I’m not pessimistic, but keep in mind that Trump’s inauguration might usher in a high-volatility period—something the market and many retail traders haven’t experienced in a while. Better safe than sorry.
SPREADEX:SPX
by TanukiTrade
4
Can We Get +EV from EV? With stocks like FCX, sometimes the answer isn’t just about gold—it’s about finding the copper that holds everything together. While everyone scrambles for the gold nuggets in the mainstream Electric Vehicle (EV) market, you might be missing opportunities further upstream in the feeder streams. These are the overlooked areas that quietly power the whole operation. As I work on my 2025 guide to researching and finding hidden gems in this very market, I stumbled upon a curious situation that’s sometimes overlooked when researching a stock: a well-timed opportunity to combine deeper research with the possibility of an early position. What is that opportunity, you ask? Well, it’s all about timing and understanding the mechanics of dividends, coupled with an upcoming earnings catalyst. The Hidden Value in Copper Let’s face it—copper wire isn’t exactly the sexiest investment out there. But sometimes, the dressed-down stock has a greater long-term value precisely because it spans multiple industries. Copper isn’t just critical for EV motors and renewable energy—it’s a foundation material for infrastructure, electronics, and more. Enter Freeport-McMoRan Inc. (FCX). This copper powerhouse caught my attention for two key reasons: 1. A dividend payout date approaching on Jan 15, offering a 1.6% yield. 2. An earnings report set for Jan 23, creating the potential for amplified movement shortly after the dividend window. Now, before you jump in, remember: this isn’t about chasing dividends or speculative hype. Instead, it’s an opportunity to observe, research, and learn. Here’s why FCX is a fascinating case study and what to watch for. Why FCX Is a Great Study 1. **Dividend Catalyst (Jan 15) - Watching the stock’s behavior leading up to and after the ex-dividend date could give insights into how investors value the dividend. - Track whether the stock trades with increased volume or volatility as traders position themselves to collect the dividend. 2. **Earnings Catalyst (Jan 23) - With earnings just a week after the ex-dividend date, you have a rare overlap of events that could amplify price movement. - Depending on sentiment, the stock could rebound from the ex-dividend price drop—or face additional pressure if earnings or guidance disappoint. 3. **Copper Exposure - FCX is already on our radar for its ties to EVs, renewable energy, and infrastructure projects. - Broader copper demand, influenced by economic sentiment or supply chain news, could add another layer of movement to this stock. What to Watch 1. Pre-Dividend Price Action (Now through Jan 14) - Look for increased buying as traders position for the dividend. - Monitor volume trends and whether FCX breaks key technical levels. - Keep an eye on market sentiment and copper-related news. 2. Ex-Dividend Price Adjustment (Jan 15) - Observe if the stock drops by exactly the dividend amount ($0.15) or if external factors cause a different adjustment. - Watch for recovery post-drop—does buying interest resume, or does the stock stall? 3. Earnings Anticipation (Jan 16–23) - Monitor implied volatility (IV) for options, as IV typically rises before earnings. - Consider how copper prices or macroeconomic trends (like China reopening or U.S. infrastructure spending) might affect sentiment heading into earnings. 4. Post-Earnings Reaction (Jan 23 and Beyond) - Listen to the earnings call for insights on copper demand, production costs, and forward contracts. - Note whether the stock aligns with broader copper and EV trends or diverges based on the results. Possible Outcomes 1. Bullish Scenario - Dividend buying drives interest, and earnings provide a strong catalyst for growth. - The stock rebounds quickly after the ex-dividend date and continues upward momentum post-earnings. 2. Bearish Scenario - Dividend adjustment leads to further downside pressure, and earnings fail to meet expectations. - The stock underperforms compared to copper peers. 3. Neutral Scenario - Dividend adjustment happens as expected, and earnings provide no surprises. - FCX trades sideways, maintaining a range-bound pattern. How to Track and Document 1. **Price & Volume:** - Record closing prices from now through Jan 23. - Note volume spikes and their timing relative to events. 2. **Options Activity:** - Monitor the options chain for changes in implied volatility as earnings approach. - Look for unusual activity around certain strikes or expirations. 3. **Copper Prices:** - Track global copper prices, as they could influence sentiment for FCX. 4. **News Flow:** - Stay updated on copper demand, EV adoption, and infrastructure-related headlines. A Practical Exercise in +EV Thinking FCX presents a unique opportunity to explore the layered dynamics of dividends, earnings, and macroeconomic trends. Even if you don’t take a position, tracking these events can sharpen your understanding of how catalysts play out in real time. And, of course, this study aligns perfectly with the philosophy behind my upcoming eBook and print guide: **“Adding to Your Nest with EV in 2025 – A guide for researching the hidden gems in the EV market sector of trading.”** So, can we get +EV from EV? The answer lies upstream, in the copper that holds everything together. -Bob Cavin 3
NYSE:FCX
by bcavin
Easyjet ready to fly?Easyjet records better financial statements, looking at the report is possible to read that LSE:EZJ flew about 5% increase in seats when compared with last year. The revenue increased by 14% this mainly because of the increase of 8% in capacity. Looking over the financial indicator it's noticeable an increase in revenue and the difference compared to 13 week moving average. The price breakout for the second time above the top of ascending triangle following for a cross over the 200ema. The yellow resistance is the strongest one that still needs to be broken. ADX is already above DMI- and being at 19,49 can show some strength confirming the DMI+. EFI barely dropped below zero when the price failed to cross the EMA changing direction above zero rapidly.
LSE:EZJLong
by AFCapital21
PALANTIR ON AN INCREDIBLE BULLRUN ! BUT... But be careful—this does not justify the price at all. Although Palantir has very solid numbers in its balance sheet, this does not justify a valuation at such an overvalued price could be very dangerous ! We must consider that markets in general are bullish, and the results of the latest report recently showed that it remains a very solid company in terms of sales. However, its earnings numbers are average—they meet analysts’ expectations, but by a very narrow margin. Historically, this has been the case in past reports as well. Now, let’s get back to the technical analysis of Palantir. After its report, it managed to break through that institutional zone that marked its peak 3 years ago (2021). After bouncing off the imbalance for a second time, Palantir showed a lot of strength and reached new highs. From here on, we just need to wait for a pullback soon to start analyzing a possible support level. Right now, Palantir is in no man’s land, which makes it a bit difficult to predict its next move. The only thing we can do here is to follow its movement candle by candle, staying alert to wicks and immediate zones where it might pull back. Thank you for supporting my analysis. TRADE SAFE!"
PLong
by RocketMike111
GOOGL Strong Move Post-Earnings. My AnalysisHey, guys. Not going to go into too much detail on the description here. Just wanted to get my thoughts out there on NASDAQ:GOOGL . Certainly seems to have a strong long term trend here. As always, in long term trends, there could be various counter trend moves so always be prepared in that regard. Hopefully this offers some more insight for you as you think about NASDAQ:GOOGL from an investment perspective, or even a trading perspective. Even if you are looking for short term trades in GOOGL, I find it helpful to know how your trade might fit in to the longer term trend (whether to the downside or upside). Hope you enjoy the review, and best of luck out there!
NYSE:MODGLong
by redykhouse
Nasdaq - Nasdaq will maintain the balance of 20,000?!The index is above the EMA200 and EMA50 in the 4H timeframe and is trading in its ascending channel If the drawn support range is maintained, we can see the index continue to climb up to the previous ATH But the valid break of the drawn support range will pave the way for the correction of the index to the bottom of the ascending channel Within the defined demand zone, one can look for index buy positions with appropriate risk-reward
CAPITALCOM:US100Long
by Ali_PSND
1
Palantir Validated a Liquidity Zone, Whats Next? If you saw my previous structural analysis, I had mentioned that Palantir was going to hit an institutional liquidity zone, and for the first time in several years, using common sense, the price was going to face rejection. And that’s exactly what happened... The price hit my point of interest and dropped for 3 days. However, the last candle with which we closed the week was green and had enough volume. Why is this? If we can see 2 candles before the close, we can detect a trap that created a long wick downward, preventing the price from falling further. That’s the detail we're seeing before the week’s close—the last candle was bullish. We also can’t ignore that Palantir is only about 2 weeks away from its earnings report. So, I don’t think the price will make a decisive move just yet, and even if it falls further, it would likely be around 38.50. However, the earnings strategy that traders are waiting for, where Palantir accumulates and begins to rise, is very close. So, we need to be very alert as we approach its earnings report on November 4th. Best regards, and thank you for supporting my analysis.
P
by RocketMike111
Google Still Bullish but nothing to see yet till Earnings ReportGoogle is clinging to this stagnant channel (yellow color), but the question is: Could this be an accumulation before their earnings report? We are one week away from Google's earnings report, and I have a feeling that the price will simply continue to trade within the same range until a few days before the report. Let's say on Friday or Monday, we may see a strong and sudden move. This is due to the "insiders," those privileged individuals within the company who hold positions and know what the price movement will be on the day of the report based on information they can access before the expected date. We just need to keep in mind that we are still in a congested sideways channel, and this channel may expand as the days leading up to the report approach. There's really not much to see with Google at the moment. Best regards, and thank you for supporting my analysis.
NASDAQ:GOOGL
by RocketMike111
2
Significant Move Expected for Walgreens Boots AllianceToday, Walgreens Boots Alliance (WBA) is highly volatile with an IVRank of 102.6, indicating elevated implied volatility. The expected move is ±11.78% in the near term, showing potential for significant price swings. Skew across expiries suggests a stronger preference for calls, as evidenced by the CALL skew of 36.5%, particularly notable for the 11/15 expiry where the IVx is 102.7%. Despite a slight IVx decline across some expiries, the volatility remains high, signaling traders are bracing for large earnings-driven moves.
NASDAQ:WBALong
by TanukiTrade